(TSX:DNG),(Pinksheets:DNGDF),(PinkSheets:DNGDF), MONTREAL, Jan. 27, 2026 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced today that its Board of Directors has approved a monthly dividend of C$0.01333 per common share (C$0.16 annually) for February 2026. This will be payable on February 17, 2026, to shareholders of record as of the close […]
(NASDAQ:CGTX), PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, conducted a Type C meeting with the U.S. Food and Drug Administration (FDA) on January 21, 2026. The objective of this meeting was to review plans for
(CNSX:TCEC.CN),(OTC US:TCEFF),(Other OTC:TCEFF),(Boerse Frankfurt – Freiverkehr:C9O0), Vancouver B.C., Jan. 27, 2026 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) welcomes the recent announcement by Governor Cox of Utah unveiling “Mission Critical” a mine-to-market state strategy for critical minerals, built with clarity, speed, and responsibility. The state
Volatus Advances Dufour Aerospace Partnership to Develop Runway-Independent Cargo Capabilities for Arctic, Defence, and Commercial Operations GlobeNewswire January 27, 2026 TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) — – Volatus Aerospace Inc. (TSX: FLT; OTCQB: TAKOF; Frankfurt: ABB.F) (“Volatus” or the “Company”), a next-generation aerospace and defence company delivering dual-use crewed and uncrewed systems, aerial intelligence,
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients GlobeNewswire January 27, 2026 9 of 25 BriaCell patients treated since 2022 remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for standard of care therapies in similar patient populations No Bria-IMT(TM) related discontinuations reported to date Bria-IMT regimen continues under
Cytokinetics Announces MYQORZO(TM) (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms GlobeNewswire January 27, 2026 MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares GlobeNewswire January 27, 2026 January 27, 2026 BOSTON, Jan. 27, 2026 (GLOBE NEWSWIRE) — Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26, 2026, it closed
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics GlobeNewswire January 27, 2026 NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced a series of
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI(R) (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum GlobeNewswire January 27, 2026 NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI(R) (ublituximab-xiiy), to be
Dragonfly Energy Launches Battle Born(R) Solar Panels Designed for Real-World Installations High-efficiency solar panels built to deliver more power, optimized with next-generation anti-shading technology GlobeNewswire January 27, 2026 RENO, Nev., Jan. 27, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker